Trial Profile
Olanzapine in the Treatment of Low Weight and Obsessional Thinking Among Those With Anorexia Nervosa: A Double Blind Placebo Controlled Study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 May 2017
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary)
- Indications Anorexia nervosa
- Focus Therapeutic Use
- 19 Dec 2008 New trial record.
- 01 Oct 2008 Results have been published in the American Journal of Psychiatry.